Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Han Si

1PUBLICATIONS
21CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jan 20, 2026
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRASG12D Inhibitor.

Ling Xie, Chunwei Xu, Han Si

Pageof 1

Frequent Collaborators

1 joint publications

Ling Xie

1 joint publications

Chunwei Xu

1 joint publications

Xiaoshuang Fu

1 joint publications

Xiangcai Yang

1 joint publications

Jianan Jin

1 joint publications

Xiaoqing Yu

1 joint publications

Zhiying Shao

1 joint publications

Yanling Wang

1 joint publications

Tianqing Chu

1 joint publications

Jun Zhang

Frequent Collaborators

1 joint publications

Ling Xie

1 joint publications

Chunwei Xu

1 joint publications

Xiaoshuang Fu

1 joint publications

Xiangcai Yang

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.6K
See more related videos

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.6K
See more related videos